For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of Tafamidis and Tafamidis meglumine represents a significant advancement . These novel https://attr-cm502683.webbuzzfeed.com/42476276/major-attr-cm-breakthrough-tafamidis-and-tafamidis-meglumine-give-promise